Chargement de la page
Logo of D.E.S is it, DES Action group in France (Diethylstilbestrol)

News with tag "DES Granddaughter"

Several cases of clear cell adenocarcinoma (CCAC) reported in DES granddaughters (diethylstilbestrol)

Several cases of Clear Cell Adenocarcinoma (CCA) in DES Granddaughters (diethylstilbestrol)

Diethylstilbestrol (DES) has been marketed in many countries by several pharmaceutical companies under different brand names. It has been widely prescribed to pregnant women to prevent miscarriages.

Thanks to a study by W.J. Dieckmann, it was known, as early as 1953 that this treatment was ineffective in pregnant women for all its indi...

Read more
DES-exposed third generation women have increased risks of menstrual aberrations, preterm birth, and possibly ectopic pregnancy - DES Granddaughters - D.E.S is it french organization

Petition for an adapted maternity leave: DES Granddaughters face special risks during pregnancy

In France, diethylstilbestrol (DES), marketed under numerous brand names such as Distilbène®, Stilboestrol-Borne® or Furostilboestrol®, has been prescribed to approximately 200,000 pregnant women, over a period of 30 years.

DES received a marketing authorization in 1945, at a time when the carcinogenic properties of ...

Read more
Russian doll (matriochka) - D.E.S Exposure - The Diethylstilbestrol Legacy

Prenatal DES exposure also induces malformations of the external genitalia in the third generation

Diethylstilbestrol, known as DES – marketed in France under the brand names Distilbène® and Stilboestrol-Borne®, is one of the most well studied endocrine disruptor to date. It is a nonsteroidal synthetic estrogen, teratogenic, carcinogenic and genotoxic.

Heralded as a medical miracle for preventing miscarriage and...

Read more
Spinner - ADHD - attention-deficit hyperactivity disorder - diethylstilbestrol - consequences of DES - diethylstilbestrol

Exposure to Diethylstilbestrol (DES) linked to Attention Deficit Hyperactivity Disorder (ADHD) in Third Generation

Diethylstilbestrol (or DES – a commonly used abbreviation) is a well-known endocrine disruptor. In France, it has been marketed under the brand names Distilbène®, Stilboestrol-Borne® and Furostilboestrol®.

It was mainly prescribed to pregnant women between 1948 and 1977, where it was banned. Its main indication...

Read more